CN115956117A - 人类人工多能干细胞的培养方法、人类人工多能干细胞培养物、以及脑类器官的制造方法 - Google Patents

人类人工多能干细胞的培养方法、人类人工多能干细胞培养物、以及脑类器官的制造方法 Download PDF

Info

Publication number
CN115956117A
CN115956117A CN202180050396.9A CN202180050396A CN115956117A CN 115956117 A CN115956117 A CN 115956117A CN 202180050396 A CN202180050396 A CN 202180050396A CN 115956117 A CN115956117 A CN 115956117A
Authority
CN
China
Prior art keywords
culture
pluripotent stem
medium
human artificial
artificial pluripotent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180050396.9A
Other languages
English (en)
Chinese (zh)
Inventor
平峯勇人
塩泽诚司
冈野荣之
石川充
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jicc 02 Co ltd
Keio University
Original Assignee
JSR Corp
Keio University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JSR Corp, Keio University filed Critical JSR Corp
Publication of CN115956117A publication Critical patent/CN115956117A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0623—Stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00—Constructional details, e.g. recesses, hinges
    • C12M23/02—Form or structure of the vessel
    • C12M23/10—Petri dish
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/04—Alpha- or beta- amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/04—Alpha- or beta- amino acids
    • C12P13/08—Lysine; Diaminopimelic acid; Threonine; Valine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • C12P17/12—Nitrogen as only ring hetero atom containing a six-membered hetero ring
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/32—Nucleotides having a condensed ring system containing a six-membered ring having two N-atoms in the same ring, e.g. purine nucleotides, nicotineamide-adenine dinucleotide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/24—Preparation of oxygen-containing organic compounds containing a carbonyl group
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/415—Wnt; Frizzeled
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/72—Transferases [EC 2.]
    • C12N2501/727—Kinases (EC 2.7.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2513/00—3D culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2527/00—Culture process characterised by the use of mechanical forces, e.g. strain, vibration

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Transplantation (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Clinical Laboratory Science (AREA)
  • Sustainable Development (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CN202180050396.9A 2020-08-21 2021-08-20 人类人工多能干细胞的培养方法、人类人工多能干细胞培养物、以及脑类器官的制造方法 Pending CN115956117A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020140133 2020-08-21
JP2020-140133 2020-08-21
PCT/JP2021/030516 WO2022039250A1 (ja) 2020-08-21 2021-08-20 ヒト人工多能性幹細胞の培養方法、ヒト人工多能性幹細胞培養物、及び脳オルガノイドの製造方法

Publications (1)

Publication Number Publication Date
CN115956117A true CN115956117A (zh) 2023-04-11

Family

ID=80322953

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180050396.9A Pending CN115956117A (zh) 2020-08-21 2021-08-20 人类人工多能干细胞的培养方法、人类人工多能干细胞培养物、以及脑类器官的制造方法

Country Status (5)

Country Link
US (1) US20230257701A1 (https=)
EP (1) EP4206320A4 (https=)
JP (1) JPWO2022039250A1 (https=)
CN (1) CN115956117A (https=)
WO (1) WO2022039250A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025223253A1 (zh) * 2024-04-23 2025-10-30 妙顺（上海）生物科技有限公司 一种神经类器官三维培养诱导分化的方法及其应用

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024204873A1 (ja) * 2023-03-30 2024-10-03 株式会社カネカ オルガノイドを用いた凝集性タンパク質に対する凝集抑制活性又は凝集促進活性を評価する方法、並びにオルガノイドの製造方法
CN119286765A (zh) * 2024-12-10 2025-01-10 山东伯桢生物科技有限公司 类器官基础培养基及维持和促进类器官生长的方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020100481A1 (ja) * 2018-11-15 2020-05-22 Jsr株式会社 脳オルガノイドの製造方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010096746A1 (en) * 2009-02-20 2010-08-26 Cellular Dynamics International, Inc. Methods and compositions for the differentiation of stem cells
US9822343B2 (en) * 2011-08-22 2017-11-21 Mayo Foundation For Medical Education And Research Methods and materials for obtaining induced pluripotent stem cells
EP2743345A1 (en) 2012-12-13 2014-06-18 IMBA-Institut für Molekulare Biotechnologie GmbH Three dimensional heterogeneously differentiated tissue culture
EP3068871B1 (en) * 2013-11-11 2020-02-12 Agency for Science, Technology and Research Method for differentiating induced pluripotent stem cells into renal proximal tubular cell-like cells
ES2732730T3 (es) 2013-11-22 2019-11-25 Riken Método para producir telencéfalo o tejido progenitor del mismo
US20180245048A1 (en) * 2015-02-25 2018-08-30 Agency For Science, Technology And Research Methods and compositions for expansion and differentiation of skeletal muscle stem cells or progenitor cells
LU92845B1 (en) * 2015-10-08 2017-05-02 Univ Du Luxembourg Campus Belval Means and methods for generating midbrain organoids
AU2018239426A1 (en) * 2017-03-21 2019-10-03 Memorial Sloan-Kettering Cancer Center Stem cell-derived astrocytes, methods of making and methods of use
WO2018185260A1 (en) * 2017-04-06 2018-10-11 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Novel human hepatocyte-derived matrix for stem-cell differentiation and tissue repair
WO2019078278A1 (ja) * 2017-10-18 2019-04-25 国立大学法人京都大学 心筋細胞に分化させるための多能性幹細胞の製造方法
CN109589337B (zh) * 2018-12-29 2022-04-26 南京艾尔普再生医学科技有限公司 心肌细胞制剂及其制备方法和应用
US20220145247A1 (en) * 2019-02-11 2022-05-12 Miltenyi Biotec B.V. & Co. KG Generation of human pluripotent stem cell derived artificial tissue structures without three dimensional matrices

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020100481A1 (ja) * 2018-11-15 2020-05-22 Jsr株式会社 脳オルガノイドの製造方法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LIAN等: "Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/b-catenin signaling under fully defined conditions", NATURE PROTOCOLS, vol. 8, no. 1, 20 December 2012 (2012-12-20), pages 1 *
WATTANAPANITCH等: "Dual Small-Molecule Targeting of SMAD SignalingStimulates Human Induced Pluripotent Stem Cellstoward NeDual Small-Molecule Targeting of SMAD SignalingStimulates Human Induced Pluripotent Stem Cellstoward Neural Lineagesural Lineages", PLOS ONE, vol. 9, no. 9, 10 September 2014 (2014-09-10), pages 4 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025223253A1 (zh) * 2024-04-23 2025-10-30 妙顺（上海）生物科技有限公司 一种神经类器官三维培养诱导分化的方法及其应用

Also Published As

Publication number Publication date
EP4206320A4 (en) 2025-02-12
US20230257701A1 (en) 2023-08-17
JPWO2022039250A1 (https=) 2022-02-24
WO2022039250A1 (ja) 2022-02-24
EP4206320A1 (en) 2023-07-05

Similar Documents

Publication Publication Date Title
CN112996906B (zh) 脑类器官的制造方法、脑类器官及其应用
Krivega et al. WNT3 and membrane-associated β-catenin regulate trophectoderm lineage differentiation in human blastocysts
Cloutier et al. Preventing erosion of X-chromosome inactivation in human embryonic stem cells
Zeng et al. Collagen/β1 integrin interaction is required for embryoid body formation during cardiogenesis from murine induced pluripotent stem cells
CN112175900A (zh) 一种多能干细胞定向分化为功能性心肌的方法
CN115956117A (zh) 人类人工多能干细胞的培养方法、人类人工多能干细胞培养物、以及脑类器官的制造方法
US12558381B2 (en) Development of amnion-like tissue from human pluripotent stem cells
US20240384232A1 (en) Clinical-grade therapeutic progenitors generated from tankyrase/parp-inhibited pluripotent stem cell banks
US12467917B2 (en) Reconstructing human early embryogenesis in vitro with pluripotent stem cells
EP4413119A1 (en) Methods for production of functional neurons
Qiao et al. SEPHS1 is dispensable for pluripotency maintenance but indispensable for cardiac differentiation in mouse embryonic stem cells
Ohgushi et al. Cell-autonomous differentiation of human primed embryonic stem cells into trophoblastic syncytia through the nascent amnion-like cell state
JP7489377B2 (ja) 多能性幹細胞を含む細胞集団及びその製造方法
CA3199729A1 (en) Induced stem cells
US20260055376A1 (en) Engineered human cardiac tissue
US20240034992A1 (en) Dopaminergic neurons comprising mutations and methods of use thereof
US20240279602A1 (en) Method for producing cerebral cortical cell preparation derived from human pluripotent stem cells
US20220017872A1 (en) Producing method for pluripotent stem cell capable of differentiating into specific cell and application thereof
WO2021145402A1 (ja) 特定細胞に分化する能力を有する多能性幹細胞の製造方法およびその応用
US20240327789A1 (en) Human cerebellar organoids with bona fide purkinje cells and uses thereof
Mabrouk Self-organization of induced pluripotent stem cells during pluripotency and early germ layer differentiation
Ross Defining the minimal and context-dependent signalling cascades regulating the maintenance of human naïve embryonic stem cells and early embryo development
WO2025006477A2 (en) System and methods for generation of human fetal progenitors, tissues, and organs from cultured stem cells
WO2024243481A1 (en) Compositions and methods for generation of bovine pluripotent embryonic stem cells
Haponen Optimization of cardiomyocyte differentiation of human pluripotent stem cells

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information

Country or region after: Japan

Address after: Japan

Applicant after: JSR Corp.

Applicant after: Keio University

Address before: Japan

Applicant before: JICC-02 Co.,Ltd.

Country or region before: Japan

Applicant before: Keio University

CB02 Change of applicant information
TA01 Transfer of patent application right

Effective date of registration: 20250728

Address after: Japan

Applicant after: JICC-02 Co.,Ltd.

Country or region after: Japan

Applicant after: Keio University

Address before: Tokyo, Japan

Applicant before: JSR Corp.

Country or region before: Japan

Applicant before: Keio University

TA01 Transfer of patent application right